StockData
CollPlant Biotechnologies Ltd logo

CollPlant Biotechnologies Ltd (OPHI) revenue by segment

OPHINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as CLGN
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30
$3.40−0.20 (-5.56%)

Close on Nov 18, 2026Market cap $4.91MP/E –Yield –

CollPlant Biotechnologies Ltd revenue by segment

By business segment

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018% of revenueYoY
Revenues from milestones$2.00M–$10.00M–––––84.4%–
Revenues from the Sales of Goods$371.00K$515.00K$959.00K$299.00K$1.60M–––15.6%-28.0%
Revenues from licensing agreement––$10.00M–$14.00M–––––
Revenues from the rendering of services––––$46.00K–––––

By region

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018% of revenueYoY
United States$2.18M$484.00K$10.84M$16.00K$14.95M$5.77M$2.08M$4.87M91.8%+349.6%
Europe and others$98.00K–$28.00K$104.00K$633.00K$369.00K$240.00K–4.1%–
Canada$96.00K–$87.00K$158.00K$57.00K–––4.0%–
Israel$1.00K$31.00K$5.00K$21.00K––––0.0%-96.8%
Total–––$299.00K$15.64M$6.14M$2.32M$5.01M––

From the segment and revenue-disaggregation notes of CollPlant Biotechnologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes. The KPIs tab shows these segments next to CollPlant Biotechnologies's operating metrics, with full history, charts and a link to each filing.

See a number that looks wrong?